MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
MEDICINOVA INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.40−0.02 (-1.41%)
Close on Oct 19, 2026
- Market cap
- $68.91M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q4 FY2025 Ended Dec 31, 2025 | Feb 20, 2026 | Before market open | – | – | – |
| Q4 FY2012 Ended Dec 31, 2012 | Mar 28, 2013 | During market hours | – | – | – |
| Q4 FY2011 Ended Dec 31, 2011 | Mar 29, 2012 | During market hours | – | – | – |
| Q3 FY2011 Ended Sep 30, 2011 | Nov 15, 2011 | Before market open | – | – | – |
| Q2 FY2011 Ended Jun 30, 2011 | Aug 16, 2011 | Before market open | – | – | – |
| Q1 FY2011 Ended Mar 31, 2011 | May 17, 2011 | Before market open | – | – | – |
| Q4 FY2010 Ended Dec 31, 2010 | Mar 24, 2011 | During market hours | – | – | – |
| Q3 FY2010 Ended Sep 30, 2010 | Nov 16, 2010 | During market hours | – | – | – |
| Q2 FY2010 Ended Jun 30, 2010 | Aug 16, 2010 | During market hours | – | – | – |
| Q4 FY2009 Ended Dec 31, 2009 | Mar 24, 2010 | During market hours | – | – | – |
| Q4 FY2008 Ended Dec 31, 2008 | Mar 31, 2009 | During market hours | – | – | – |
| Q4 FY2007 Ended Dec 31, 2007 | Feb 8, 2008 | Before market open | – | – | – |
Press releases
Announcements Medicinova filed with the SEC
for the Fiscal Year Ended December 31, 2025
Results of operations · EX-99.1 to Form 8-K